View the METHARAN N registration information details.
Back to drug list
ItemsDrug Registration information
ID2201
No2201
Brand NameMETHARAN N
IngredientsBETAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V, NEOMYCINE SULFATE BP 0.5 %W/V,THIOMERSAL BP 0.005 % W/V
Dosage FormSOLUTION
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size10 ML/BOTTLE/CARTON
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsEYE: SHORT TERM TREATMENT OF STEROID RESPONSIVE INFLAMMATORY, EAR: OTITIS EXTERNA OR OTHER STEROID RESPONSIVE, NOSE: STEROID RESPONSIVE INFLAMMATORY CONDITIONS WHERE PROPHYLACTIC ANTIBIOTIC TREATMENT IS ALSO REQUIRED
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionCLEAR COLORLESS TO YELLOWISH LIQUID FILLED IN WHITE PLASTIC BOTTLE
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerBRAWN LABORATORIES LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4672/19
FDD Registration Date06/12/2022
Expiry Date05/12/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA